At-home HPV screening takes center stage in this upbeat news announcement about a commercial rollout designed to broaden patient access.
Key Takeaways
- FDA-cleared Onclarity HPV self-collection kit detects 14 high-risk HPV genotypes
- SNT Biotech will distribute kits using a population-health platform with outreach and lab processing
- Federal guidelines should make self-collected HPV screening cost-free for most insurers by 2027